Loading…

Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR-ERK independent of epithelial-mesenchymal transition

Breast cancer is the second most common type of cancer and the leading cause of cancer death in women worldwide. Adjuvant tamoxifen therapy significantly slows down estrogen receptor (ER)-positive breast cancer progression, prolongs diseasefree survival, and contributes to the decrease in breast can...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular cell biology 2014-08, Vol.6 (4), p.352-354
Main Authors: Jiang, Yan, Zhao, Xiaotong, Xiao, Qian, Liu, Qingbo, Ding, Keshuo, Yu, Fei, Zhang, Rui, Zhu, Tao, Ge, Gaoxiang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Breast cancer is the second most common type of cancer and the leading cause of cancer death in women worldwide. Adjuvant tamoxifen therapy significantly slows down estrogen receptor (ER)-positive breast cancer progression, prolongs diseasefree survival, and contributes to the decrease in breast cancer mortality (Musgrove and Sutherland, 2009). However, majority of the death from breast cancer is due to metastasis that is resistant to therapy (Musgrove and Sutherland, 2009).
ISSN:1674-2788
1759-4685
DOI:10.1093/jmcb/mju019